Exploring real-world place and clinical predictors of soluble guanylate cyclase stimulators (vericiguat) eligibility for the treatment of heart failure with reduced ejection fraction (hfref)
Journal of the American College of Cardiology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined